🇺🇸 FDA
Patent

US 8535687

Smallpox DNA vaccine and the antigens therein that elicit an immune response

granted A61KA61K2039/53A61K2039/545

Quick answer

US patent 8535687 (Smallpox DNA vaccine and the antigens therein that elicit an immune response) held by Inovio Pharmaceuticals, Inc. expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/53, A61K2039/545, A61K39/12, A61K39/285